Effect of the aggregated protein dye YAT2150 on Leishmania parasite viability
Amastigote
IC50
DOI:
10.1128/aac.01127-23
Publication Date:
2024-02-13T14:01:29Z
AUTHORS (15)
ABSTRACT
ABSTRACT The problems associated with the drugs currently used to treat leishmaniasis, including resistance, toxicity, and high cost of some formulations, call for urgent identification new therapeutic agents novel modes action. aggregated protein dye YAT2150 has been found be a potent antileishmanial compound, half-maximal inhibitory concentration (IC 50 ) approximately 0.5 µM against promastigote amastigote stages Leishmania infantum . encapsulation in liposomes significantly improved its vitro IC 0.37 0.19 promastigotes amastigotes, respectively, increased cytotoxic human umbilical vein endothelial cells >50 µM. became strongly fluorescent when binding intracellular deposits cells. This fluorescence pattern aligns proposed mode action this drug malaria parasite Plasmodium falciparum , inhibition aggregation. In major rapidly reduced ATP levels, suggesting an alternative mechanism. To best our knowledge, first-in-class compound is only one described so far having significant activity both thus being potential treatment co-infections parasites.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (65)
CITATIONS (5)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....